title: The English National Screening Programme for diabetic retinopathy 2003-2016.
abstract: The aim of the English NHS Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment if necessary of sight-threatening diabetic retinopathy, at the appropriate stage during the disease process. In order to achieve the delivery of evidence-based, population-based screening programmes, it was recognised that certain key components were required. It is necessary to identify the eligible population in order to deliver the programme to the maximum number of people with diabetes. The programme is delivered and supported by suitably trained, competent, and qualified, clinical and non-clinical staff who participate in recognised ongoing Continuous Professional Development and Quality Assurance schemes. There is an appropriate referral route for those with screen-positive disease for ophthalmology treatment and for assessment of the retinal status in those with poor-quality images. Appropriate assessment of control of their diabetes is also important in those who are screen positive. Audit and internal and external quality assurance schemes are embedded in the service. In England, two-field mydriatic digital photographic screening is offered annually to all people with diabetes aged 12 years and over. The programme commenced in 2003 and reached population coverage across the whole of England by 2008. Increasing uptake has been achieved and the current annual uptake of the programme in 2015-16 is 82.8% when 2.59 million people with diabetes were offered screening and 2.14 million were screened. The benefit of the programme is that, in England, diabetic retinopathy/maculopathy is no longer the leading cause of certifiable blindness in the working age group.
authors.affiliation: The English NHS Diabetic Eye Screening Programme, Gloucestershire Diabetic Retinopathy Research Group, Office above Oakley Ward, Cheltenham General Hospital, Sandford Road, Cheltenham, GL53 7AN, UK. peter.scanlon@glos.nhs.uk.|Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, UK. peter.scanlon@glos.nhs.uk.
authors.forename: Peter H
authors.initials: PH
authors.lastname: Scanlon
mesh_terms: D003930:Diabetic Retinopathy / Q000175:diagnosis* / Q000453:epidemiology; D003941:Diagnostic Techniques, Ophthalmological / Q000706:statistics & numerical data; D004739:England / Q000453:epidemiology; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D009313:National Health Programs / Q000458:organization & administration / Q000592:standards; D010781:Photography; D012017:Referral and Consultation; D013222:State Medicine
keywords: Blindness; Diabetic retinopathy; Screening